A new drug developed by Lancaster University which may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials. Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.
MAC is delighted to announce that it has won the highly coveted Health and Care Business of the Year Award
MAC Clinical Research has opened a new phase I/IIa clinic at Citylabs in Manchester, expanding its phase I services in
We are delighted to annouce that MAC has been shortlisted for Bionow’s Technical Service of the Year Award. The Bionow awards celebrate and
We are delighted to welcome Dr John Connell to MAC who will lead our pharmacodynamic offering. Dr Connell completed his
MAC’s pain experts were on hand at the 15th World Congress on Pain this week. The team met with many
THCV improves glycaemic control in Type 2 Diabetes “Diabetes is at crisis levels”: The International Diabetes Foundation calculate that 366
MAC had a team of Business Development personnel and Scientists at this years Partnerships in Clinical Trials Congress in Vienna.
MAC Clinical Research recently presented at the 8th biennial Congress of the European Federation of IASP® Chapters (EFIC 2013), which was held in Florence, Italy, 9-12 October 2013.
Members of the MAC Blackpool team were present to support the 2013 Fylde Coast Health Mela on Saturday 5th October, which was held in the Winter Gardens in Blackpool. This was the first ever health Mela to be held in the area and MAC were happy to aid its cause.
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
